Transmucosal Absorption Enhancers in the Drug Delivery Field

被引：29

作者：

Maher, Sam ^{[1
]}

Casettari, Luca ^{[2
]}

Illum, Lisbeth ^{[3
]}

机构：

[1] Royal Coll Surgeons Ireland, Sch Pharm, St Stephens Green, Dublin 2, Ireland

[2] Univ Urbino Carlo Bo, Dept Biomol Sci, Piazza Rinascimento 6, I-61029 Urbino, PU, Italy

[3] IDentity, 19 Cavendish Crescent North, Nottingham NG7 1BA, England

来源：

PHARMACEUTICS | 2019年 / 11卷 / 07期

关键词：

permeation enhancers; absorption modifying excipients; oral delivery; nasal delivery; ocular delivery; vaginal delivery; transmucosal permeation; IN-VITRO; FORMULATION; PERMEATION; CALCITONIN; INSULIN;

D O I：

10.3390/pharmaceutics11070339

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Drug delivery systems that safely and consistently improve transport of poorly absorbed compounds across epithelial barriers are highly sought within the drug delivery field. The use of chemical permeation enhancers is one of the simplest and widely tested approaches to improve transmucosal permeability via oral, nasal, buccal, ocular and pulmonary routes. To date, only a small number of permeation enhancers have progressed to clinical trials, and only one product that includes a permeation enhancer has reached the pharmaceutical market. This editorial is an introduction to the special issue entitled Transmucosal Absorption Enhancers in the Drug Delivery Field (https://www.mdpi.com/journal/pharmaceutics/special_issues/transmucosal_absorption_enhancers). The guest editors outline the scope of the issue, reflect on the results and the conclusions of the 19 articles published in the issue and provide an outlook on the use of permeation enhancers in the drug delivery field.

引用

页数：10

共 51 条

[1] Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials [J].

Aguirre, T. A. S. ;

Teijeiro-Osorio, D. ;

Rosa, M. ;

Coulter, I. S. ;

Alonso, M. J. ;

Brayden, D. J. .

ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :223-241

[2] Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats [J].

Alama, Tammam ;

Kusamori, Kosuke ;

Morishita, Masaki ;

Katsumi, Hidemasa ;

Sakane, Toshiyasu ;

Yamamoto, Akira .

PHARMACEUTICS, 2019, 11 (04)

[3] Mechanistic studies of a cell-permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia [J].

Almansour, Khaled ;

Taverner, Alistair ;

Eggleston, Ian M. ;

Mrsny, Randall J. .

JOURNAL OF CONTROLLED RELEASE, 2018, 279 :208-219

[4]

[Anonymous], SUMM PROD CHAR NORD

[5] Ionic liquids for oral insulin delivery [J].

Banerjee, Amrita ;

Ibsen, Kelly ;

Brown, Tyler ;

Chen, Renwei ;

Agatemor, Christian ;

Mitragotri, Samir .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (28) :7296-7301

[6] Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant [J].

Bento, Dulce ;

Jesus, Sandra ;

Lebre, Filipa ;

Goncalves, Teresa ;

Borges, Olga .

PHARMACEUTICS, 2019, 11 (02)

[7] Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability [J].

Bocsik, Alexandra ;

Grof, Ilona ;

Kiss, Lorand ;

Otvos, Ferenc ;

Zsiros, Otto ;

Daruka, Lejla ;

Fulop, Livia ;

Vastag, Monika ;

Kittel, Agnes ;

Imre, Norbert ;

Martinek, Tamas A. ;

Pal, Csaba ;

Szabo-Revesz, Piroska ;

Deli, Maria A. .

PHARMACEUTICS, 2019, 11 (02)

[8] Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery [J].

Bruinsmann, Franciele Aline ;

Pigana, Stefania ;

Aguirre, Tanira ;

Souto, Gabriele Dadalt ;

Pereira, Gabriela Garrastazu ;

Bianchera, Annalisa ;

Fasiolo, Laura Tiozzo ;

Colombo, Gaia ;

Marques, Magno ;

Pohlmann, Adriana Raffin ;

Guterres, Silvia Staniscuaski ;

Sonvico, Fabio .

PHARMACEUTICS, 2019, 11 (02)

[9] Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist [J].

Buckley, Stephen T. ;

Baekdal, Tine A. ;

Vegge, Andreas ;

Maarbjerg, Stine J. ;

Pyke, Charles ;

Ahnfelt-Ronne, Jonas ;

Madsen, Kim G. ;

Scheele, Susanne G. ;

Alanentalo, Tomas ;

Kirk, Rikke K. ;

Pedersen, Betty L. ;

Skyggebjerg, Rikke B. ;

Benie, Andrew J. ;

Strauss, Holger M. ;

Wahlund, Per-Olof ;

Bjerregaard, Simon ;

Farkas, Erzsebet ;

Fekete, Csaba ;

Sondergaard, Flemming L. ;

Borregaard, Jeanett ;

Hartoft-Nielsen, Marie-Louise ;

Knudsen, Lotte Bjerre .

SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (467)

[10] Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles [J].

Chalasani, Kishore B. ;

Russell-Jones, Gregory J. ;

Jain, Akhlesh K. ;

Diwan, Prakash V. ;

Jain, Sanjay K. .

JOURNAL OF CONTROLLED RELEASE, 2007, 122 (02) :141-150

← 1 2 3 4 5 6 →